Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.111
+0.001 (0.04%)
Dec 27, 2024, 4:00 PM EST - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $164.62 million as of December 27, 2024. Its market cap has decreased by -20.26% in one year.
Market Cap
164.62M
Enterprise Value
105.91M
1-Year Change
-20.26%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $164.62M, an increase of 31.47%. That is a compound annual growth rate of 2.37%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ventyx Biosciences | 164.76M |
| Actuate Therapeutics | 164.07M |
| Sagimet Biosciences | 163.55M |
| Sutro Biopharma | 162.44M |
| Pro-Dex | 162.02M |
| Aligos Therapeutics | 160.97M |
| EUDA Health Holdings | 160.85M |
| Corbus Pharmaceuticals Holdings | 160.04M |